You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cevostamab

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed or Refractory Multiple Myeloma Trial (Cevostamab, Elranatamab, Tocilizumab)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Cevostamab
  • +2 more
  • (no location specified)
Jun 22, 2023

Relapsed/Refractory Multiple Myeloma Trial in Philadelphia (Cevostamab)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Cevostamab
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Apr 7, 2023

Multiple Myeloma Trial in Athens (Cevostamab, XmAb24306, Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Cevostamab
  • +2 more
  • Athens, Greece
  • +1 more
Jan 2, 2023

Multiple Myeloma Trial in Nashville (Cevostamab, Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Nashville, Tennessee
    Tennessee Onc., PLLC - SCRI
Sep 8, 2022

Multiple Myeloma Trial in Worldwide (Cevostamab, Tocilizumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Cevostamab
  • +4 more
  • Duarte, California
  • +7 more
Aug 17, 2022

Multiple Myeloma Trial in Worldwide (Cevostamab, Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +17 more
Jan 23, 2023

Multiple Myeloma Trial in Korea, Republic of, Poland, Spain (Cevostamab, Lenalidomide, Tocilizumab)

Not yet recruiting
  • Multiple Myeloma
  • Cevostamab
  • +2 more
  • Seoul, Korea, Republic of
  • +4 more
Jan 11, 2023